Related Experiment Video
Updated: May 14, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Chronic Granulomatous Interstitial Nephritis Presenting Five Years After Intravesical Bacillus Calmette-Guérin
Mehdi El Mansouri1, Hanane Benali1, Ismail Ait Elkihal1,2
1Nephrology, Mohammed VI University Center Hospital, Marrakech, MAR.
Abstract:
Intravesical administration of Bacillus Calmette-Guérin (BCG) has been the standard treatment for non-muscle invasive bladder cancer (NMIBC). Its efficacy in preventing recurrence and tumor progression has been well established; however, rare immune-mediated complications, particularly parenchymal renal involvement, pose significant diagnostic challenges. This report describes an exceptional case: that of a 73-year-old man who developed renal failure five years after his last BCG instillation. Histopathological examination revealed granulomatous interstitial nephritis. This case is remarkable for its exceptionally long and unusual latency period, which generally manifests within days to months in other patients. After initiating corticosteroid therapy, the patient experienced partial renal recovery and stabilization of renal function during follow-up, highlighting the potential role of immunological mechanisms in delayed renal injury. This study underscores the need for long-term renal monitoring in patients treated with BCG immunotherapy.
Related Concept Videos
Acute Pyelonephritis I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Urinary Tract Infection II: Pathophysiology
Urinary Tract Calculi VI: Surgical Management
Chronic Inflammation: Introduction